Skip to search formSkip to main contentSkip to account menu

BMY 21190

Known as: BMY-21190, BMY21190 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
This study was performed to assess the effect of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size using a canine… 
1994
1994
A number of compounds capable of inhibiting the aggregation of blood platelets have been reported in recent years. Synthesized… 
1993
1993
BMY21190, an inhibitor of cyclic AMP phosphodiesterase, has a coronary vasodilating effect. BMY21190 was evaluated for its…